MDXGMiMedx Group, Inc.
$4.61-37% 1Y
$4.61
$3.0952 weeks$7.96
The financials
MiMedx Group, Inc. by the numbers
MiMedx Group, Inc. (MDXG) reported revenue of $64M in Q2 2026 (quarter ended Jun 30, 2026), down 35% from the same quarter a year earlier. That came with a gross margin of 69% and net loss of $15M. For the full year FY2025, revenue was $419M (+20% year on year) and net income $49M. The next results filing is expected around Oct 28, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $64M | $99M | −35% |
| Gross profit | $44M | $80M | −44% |
| Operating income | −$18M | $12M | to a loss |
| Net income | −$15M | $9.6M | to a loss |
| Diluted EPS | −$0.10 | $0.06 | to a loss |